General Information of Drug Transporter (DT)
DT ID DTD0373 Transporter Info
Gene Name SLC46A2
Transporter Name Thymic stromal cotransporter homolog
Gene ID
57864
UniProt ID
Q9BY10
Post-Translational Modification of This DT
Overview of SLC46A2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-N-glycosylation X-Phosphorylation X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC46A2 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

235

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC46A2 Lysine 235 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC46A2 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

55

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC46A2 Asparagine 55 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC46A2 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

57

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC46A2 Serine 57 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC46A2 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

59

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC46A2 Serine 59 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC46A2 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

61

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC46A2 Serine 61 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC46A2 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

108

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC46A2 Serine 108 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC46A2 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

112

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC46A2 Serine 112 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC46A2 [3]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

372

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC46A2 Tyrosine 372 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC46A2 [3]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

375

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC46A2 Tyrosine 375 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: TSCOT_HUMAN)
2 Phosphoproteomic profiling of tumor tissues identifies HSP27 Ser82 phosphorylation as a robust marker of early ischemia. Sci Rep. 2015 Sep 2;5:13660.
3 The phosphoproteome of human Jurkat T cell clones upon costimulation with anti-CD3/anti-CD28 antibodies. J Proteomics. 2016 Jan 10;131:190-198.
4 Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.